arrow
K

Kei Ikeda

dokkyo medical university
H指数:39
被引数:6,900

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Single-cell analysis reveals transcriptomic patterns in active macrophage activation syndrome and therapeutic potential of albumin-fused interleukin-10 in a mouse model

单细胞分析揭示活动性巨噬细胞活化综合征中的转录组模式及白蛋白融合白细胞介素-10在小鼠模型中的治疗潜力

2026-11-130
OA
Perspectives of rheumatologists on the management of late-onset rheumatoid arthritis: a nationwide cross-sectional survey

风湿病学家对迟发性类风湿关节炎管理的观点:一项全国性横断面调查

2026-11-120
PRE
Circulating microRNAs associated with tumour necrosis factor or fibroblast-like synoviocytes predict cartilage damage in early rheumatoid arthritis treated with methotrexate plus adalimumab: a subanalysis of the MIRACLE study

与肿瘤坏死因子或成纤维样滑膜细胞相关的循环microRNAs可预测接受甲氨蝶呤联合阿达木单抗治疗的早期类风湿关节炎患者的软骨损伤:MIRACLE研究的亚组分析

2026-03-011
PRE
Factors and outcomes related to clinical inertia in systemic lupus erythematosus: a multicentre LUNA cohort study

与系统性红斑狼疮临床惰性相关的因素和结局:一项多中心LUNA队列研究

2025-10-010
PRE
Protocol: Filgotinib in addition to methotrexate versus filgotinib monotherapy in patients with rheumatoid arthritis with an inadequate response to methotrexate: A multicenter, prospective, open-label, randomized controlled trial (FAITHFUL Study)

方案:甲氨蝶呤联合菲尔戈替尼与菲尔戈替尼单药治疗对甲氨蝶呤反应不足的类风湿关节炎患者的多中心、前瞻性、开放标签、随机对照试验(FAITHFUL 研究)

2025-05-190
OA
Identifying two pathways to poor prognosis in patients with anti-MDA5 antibodies: insights from prognostic factor and cytokines analysis

识别抗MDA5抗体阳性患者不良预后的两条途径:来自预后因素和细胞因子分析的见解

2025-04-160
OA
Impact of an artificial intelligence-aided endoscopic diagnosis system on improving endoscopy quality for trainees in colonoscopy: Prospective, randomized, multicenter study
2023-05-2924
OA
Reduced versus maximum tolerated methotrexate dose concomitant with adalimumab in patients with rheumatoid arthritis (MIRACLE): a randomised, open-label, non-inferiority trial
2023-04-014
OAAI
Antibody responses to BNT162b2 mRNA COVID-19 vaccine and their predictors among healthcare workers in a tertiary referral hospital in Japan

日本三级转诊医院医护人员对BNT162b2 mRNA新型冠状病毒肺炎疫苗的抗体反应及其预测因子

2021-12-0194
OA